190
Views
7
CrossRef citations to date
0
Altmetric
Review

Extended-release morphine sulfate in treatment of severe acute and chronic pain

&
Pages 191-200 | Published online: 21 Sep 2010

References

  • BreastedJGAncient Records of EgyptChicago, ILUniversity of Chicago Press1930
  • BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician200811S105S12018443635
  • SchwarzSHuxtableRThe isolation of morphineMol Interv200118991
  • The Role of Chemistry in History Available from: http://itech.dickinson.edu/chemistry/?cat=107. Accessed in February, 2010.
  • BlakemorePWhiteJMorphine, the proteus of organic moleculesChem Commun (Camb)2002111159116812109065
  • PertCBSnyderSHOpiate receptor: Its demonstration in nervous tissueScience1973179101110144687585
  • HughesJSmithTKosterlitzHFothergillLMorganBMorrisHIdentification of two related pentapeptides from the brain with potent opiate agonist activityNature19752585775801207728
  • TrescotADattaSLeeMHansenHOpioid pharmacologyPain Physician200811S133S15318443637
  • McCleaneGSmithHOpioids for persistent noncancer painMed Clin N Am20079117719717321280
  • ChahlLAOpioids – mechanism of actionAust Prescr1996196365
  • NestlerEJMolecular basis of long-term plasticity underlying addictionNat Rev Neurosci2001211912811252991
  • StoeltingRKPharmacology, Physiology and Anesthetic Practice2nd edBaltimore, MDLippincott Williams and Wilkins1991
  • HasslesstromJSaweJMorphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrationsClin Pharmacokinet200140344354
  • LotschJGeisslingerGMorphine-6-glucuronide: An analgesic of the future?Clin Pharmacokinet20014048549911510626
  • DonnellySDavisMPWalshDNaughtonMMorphine in cancer pain managementSupport Care Cancer200210133511777184
  • ProjeanDMorinPETuTMDucharmaJIdentification of CYP3A4 and CYP2C8 as the major cytochrome P450s responsible for morphine N-demethylation in human liver microsomesXenobiotica20033384185412936704
  • TrescotAMBoswellMVAtluriSLOpioid guidelines in the management of chronic non-cancer painPain Physician2006914016700278
  • McCarbergBBarkinRLong-acting opioids for chronic pain; pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesiaAm J Ther2001818118611344385
  • KaplanRParrisWCCitronMLComparison of controlled-release and immediate-release oxycodone tablets AVINZA and chronic noncancer pain – 263 inpatients with cancer painJ Clin Oncol199816323032379779696
  • CaldwellJRHaleMEBoydRETreatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: A double blind, randomized, multicenter, placebo controlled trialJ Rheumatol19992686286910229408
  • KlepstedPKaasaSJystadAHvalBBorchgrevinkPCImmediate or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trialPain200310119319812507714
  • American Pain SocietyPrinciples of Analgesic Use in the Treatment of Acute Pain and Cancer PainGlenview, ILAmerican Pain Society2003
  • AdamsEHChwieckoPAce-WagonerYA study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions – The ACCPT StudyPain Pract2006625426417129306
  • RauckRLWhat is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical reviewPain Pract2009946847919874536
  • MS Contin® (morphine sulfate). Package insertStamford, CTPurdue Fredrick2004
  • LeslieSThe Contin delivery system: Dosing considerationsJ Allergy Clin Immunol1986787687733771963
  • BorodaCMillerRBLeslieSTNicolEGThomsonIComparison of the bioavailability of aminophylline in a conventional base and in a continuous-release baseJ Clin Pharmacol1973133833874490662
  • AmabileCMBowmanBJOral modified-release opioid products for chronic pain managementAnn Pharmacother2006401327133516868222
  • GourlayGKSustained relief of chronic pain pharmacokinetics of sustained release morphineClin Pharmacokinet1998351731909784932
  • Oramorph® (morphine sulfate). Package insertNewport, KYXanodyne Pharmaceuticals2006
  • Kadian® (morphine sulfate). Package insertPiscataway, NJAlpharma Pharmaceuticals2004
  • Avinza® (morphine sulfate). Package insertBristol, TNKing Pharmaceuticals2008
  • SemenchukMRAvinzaCurr Opin Invest Drugs20023136972
  • Embeda® (morphine sulfate). Package insertBristol, TNKing Pharmaceuticals2009
  • ArkinstallWWGoughnourBRWhiteJAStewartJHControl of severe pain with sustained-release morphine tablets v. oral morphine solutionCMAJ19891406536576612645988
  • FerrellBWisdomCWenzlCBrownJEffects of controlled-released morphine on quality of life for cancer painOncol Nurs Forum1989165215262755859
  • KerrROTesterWJA patient preference study comparing two extended-release morphine sulfate formulations for cancer painClin Drug Invest2000192532
  • VallerandAHThe use of long-acting opioids in chronic pain managementNurs Clin North Am20033843544514567201
  • KlepstadPKaasaSJystadAHvalBBorchgrevinkPCImmediate-or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trialPain200310119319812507714
  • RothSHFleisschmannRMBurchFXAround-the-clock controlled-release oxycodone therapy for osteoarthritis-related pain: Placebo-controlled trial and long-term evaluationArch Intern Med200016085386010737286
  • PortenoyRKSciberrasAEliotLSteady-state pharmacokinetic comparisons of a new, extended-release, once-daily morphine formulation, AVINZA®, and a twice daily controlled-release morphine formulation in patients with chronic moderate-to-severe painJ Pain Symptom Manage20022329230011997198
  • BroomheadAKerrRTesterWComparison of a once-a-day sustained release morphine formulation with standard oral morphineJ Pain Symptom Manage19971463739262035
  • SchobelockMJShepardKVMosdellKWMultiple-dose pharma-cokinetic evaluation of two formulations of sustained release morphine sulfate tabletsCurr Ther Res19955610091021
  • HomsiJWalshDLasheenWA comparative study of 2 sustained-release morphine preparations for pain in advanced cancerAm J Hosp Palliat Care2010279910519776372
  • WonALapaneKLVallowSScheinJMorrisJNLipsitzLALong-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant painJ Gerontol A Biol Sci Med Sci20066116516916510860
  • RosenthalMMoorePGrovesESleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA®): Findings from a pilot studyJ Opioid Manag20073314515418027540
  • CaldwellJRHaleMEBoydRETreatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: A double blind, randomized, multicenter, placebo controlled trialJ Rheumatol19992686286910229408
  • HaleMEFleischmannRSalzmanREfficacy and safety of controlled-release versus immediate-release oxycodone: Randomized, double-blind evaluation in patients with chronic back painClin J Pain19991517918310524470
  • BodaliaBMcDonaldCJSmithKJO’BrienCCousensLA comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsulesJ Pain Symptom Manage20032514214912590030
  • WebsterLRBrewerRSekoraDMorrisDWangCStaufferJAnalgesic efficacy outcomes from a 12-month open-label safety study of morphine sulfate plus sequestered naltrexone HCl extended-release capsules (ALO-01) in patients with chronic, moderate-to-severe, non-malignant painAmerican Academy of Pain Medicine 25th Annual MeetingJanuary 28–31, 2009Honolulu, HI